Metraipolis › archive › dc_e0115e32f083

Development of a laboratory-based nomogram for predicting clinical outcomes in patients with severe COVID-19 undergoing glucocorticoid therapy — Europe PMC PMID:41426569

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41426569
DOI
10.3389/fmed.2025.1635545
License (as archived)
solo-consultazione
Archived
2026-11-07T21:26:56.051Z
SHA-256 of the archived text
76edd0420028fdc08c4b4033f7e7869380b07b3ca32dd1ea90688245c8c70e1a
Stable URL of this page
https://metraipolis.com/documento/dc_e0115e32f083

How to cite

Development of a laboratory-based nomogram for predicting clinical outcomes in patients with severe COVID-19 undergoing glucocorticoid therapy — Europe PMC PMID:41426569 — Europe PMC (en), https://europepmc.org/article/MED/41426569 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e0115e32f083 (Metraipolis archive dc_e0115e32f083, sha256 76edd0420028fdc08c4b4033f7e7869380b07b3ca32dd1ea90688245c8c70e1a)
BibTeX
@misc{dce0115e32f083,
  title = {Development of a laboratory-based nomogram for predicting clinical outcomes in patients with severe COVID-19 undergoing glucocorticoid therapy — Europe PMC PMID:41426569},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41426569},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e0115e32f083; sha256 76edd0420028fdc08c4b4033f7e7869380b07b3ca32dd1ea90688245c8c70e1a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41426569. Agents can read the archived copy with the MCP tool read_document.